The contrasting effect of macromolecular crowding on amyloid fibril formation

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Ma, Qian ^a   Fan, Jun Bao ^a   Zhou, Zheng ^a   Zhou, Bing Rui ^a   Meng, Sheng Rong ^a   Hu, Ji Ying ^a   Chen, Jie ^a   Liang, Yi ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; AMYLOID; ASPARAGINE; ASPARTIC ACID; COPPER ZINC SUPEROXIDE DISMUTASE; DEXTRAN; FICOLL; GLUTAMIC ACID; GLYCOGEN SYNTHASE KINASE 3BETA; LYSINE; LYSOZYME; MUTANT PROTEIN; PRION PROTEIN; TAU PROTEIN; THIOFLAVINE; VALINE; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; PEPTIDE FRAGMENT; POLYMER; THIAZOLE DERIVATIVE;

ARTICLE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FIBER; MACROMOLECULE; NONHUMAN; PROTEIN AGGREGATION; TURBIDITY; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; HUMAN; METABOLISM; PHOSPHORYLATION; PRION; PROTEIN MULTIMERIZATION; PROTEIN SECONDARY STRUCTURE; RABBIT;

ORYCTOLAGUS CUNICULUS;

AMYLOID; ANIMALS; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MODELS, MOLECULAR; MURAMIDASE; PEPTIDE FRAGMENTS; PHOSPHORYLATION; POLYMERS; PRIONS; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, SECONDARY; RABBITS; TAU PROTEINS; THIAZOLES;

EID: 84860446148     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036288     Document Type: Article

References (48)

1. Dobson CM, (2003) Protein folding and misfolding. Nature 426: 884-890.
2. Mo ZY, Zhu YZ, Zhu HL, Fan JB, Chen J, et al. (2009) Low micromolar zinc accelerates the fibrillization of human Tau via bridging of Cys-291 and Cys-322. J Biol Chem 284: 34648-34657.
3. Zhu HL, Fernández C, Fan JB, Shewmaker F, Chen J, et al. (2010) Quantitative characterization of heparin binding to Tau protein. Implication for inducer-mediated Tau filament formation. J Biol Chem 285: 3592-3599.
4. Zhu HL, Meng SR, Fan JB, Chen J, Liang Y, (2011) Fibrillization of human Tau is accelerated by exposure to lead via interaction with His-330 and His-362. PLoS One 6: e25020.
5. Minton AP, (2006) How can biochemical reactions within cells differ from those in test tubes? J Cell Sci 119: 2863-2869.
6. Ellis RJ, (2001) Macromolecular crowding: an important but neglected aspect of the intracellular environment. Curr Opin Struct Biol 11: 114-119.
7. Zhou HX, Rivas G, Minton AP, (2008) Macromolecular crowding and confinement: biochemical, biophysical, and potential physiological consequences. Annu Rev Biophys 37: 375-397.
8. Spitzer J, (2011) From water and ions to crowded biomacromolecules: in vivo structuring of a prokaryotic cell. Microbiol Mol Biol Rev 75: 491-506.
9. Zhou BR, Liang Y, Du F, Zhou Z, Chen J, (2004) Mixed macromolecular crowding accelerates the oxidative refolding of reduced, denatured lysozyme: implications for protein folding in intracellular environments. J Biol Chem 279: 55109-55116.
10. Du F, Zhou Z, Mo ZY, Shi JZ, Chen J, et al. (2006) Mixed macromolecular crowding accelerates the refolding of rabbit muscle creatine kinase: implications for protein folding in physiological environments. J Mol Biol 364: 469-482.
11. Zhou Z, Fan JB, Zhu HL, Shewmaker F, Yan X, et al. (2009) Crowded cell-like environment accelerates the nucleation step of amyloidogenic protein misfolding. J Biol Chem 284: 30148-30158.
12. Jiao M, Li HT, Chen J, Minton AP, Liang Y, (2010) Attractive protein-polymer interactions markedly alter the effect of macromolecular crowding on protein association equilibria. Biophys J 99: 914-923.
13. Zhou Z, Yan X, Pan K, Chen J, Xie ZS, et al. (2011) Fibril formation of the rabbit/human/bovine prion proteins. Biophys J 101: 1483-1492.
14. Munishkina LA, Ahmad A, Fink AL, Uversky VN, (2008) Guiding protein aggregation with macromolecular crowding. Biochemistry 47: 8993-9006.
15. Johansen D, Jeffries CM, Hammouda B, Trewhella J, Goldenberg DP, (2011) Effects of macromolecular crowding on an intrinsically disordered protein characterized by small-angle neutron scattering with contrast matching. Biophys J 100: 1120-1128.
16. Prusiner SB, (1998) Prions. Proc Natl Acad Sci USA 95: 13363-13383.
17. Goedert M, (1993) Tau protein and the neurofibrillary pathology of Alzheimer's disease. Trends Neurosci 16: 460-465.
18. Polymenidou M, Cleveland DW, (2011) The seeds of neurodegeneration: prion-like spreading in ALS. Cell 147: 498-508.
19. Wickner S, Maurizi MR, Gottesman S, (1999) Posttranslational quality control: folding, refolding, and degrading proteins. Science 286: 1888-1893.
20. Lee SJ, Desplats P, Sigurdson C, Tsigelny I, Masliah E, (2010) Cell-to-cell transmission of non-prion protein aggregates. Nat Rev Neurol 6: 702-706.
21. Soto C, (2011) Prion hypothesis: the end of the controversy? Trends Biochem Sci 36: 151-158.
22. Capellari S, Strammiello R, Saverioni D, Kretzschmar H, Parchi P, (2011) Genetic Creutzfeldt-Jakob disease and fatal familial insomnia: insights into phenotypic variability and disease pathogenesis. Acta Neuropathol 121: 21-37.
23. Wang Q, Johnson JL, Agar NYR, Agar JN, (2008) Protein aggregation and protein instability govern familial amyotrophic lateral sclerosis patient survival. PLoS Biol 6: e170.
24. Ip P, Mulligan VK, Chakrabartty A, (2011) ALS-causing SOD1 mutations promote production of copper-deficient misfolded species. J Mol Biol 409: 839-852.
25. Vorberg I, Groschup MH, Pfaff E, Priola SA, (2003) Multiple amino acid residues within the rabbit prion protein inhibit formation of its abnormal isoform. J Virol 77: 2003-2009.
26. Nisbet RM, Harrison CF, Lawson VA, Masters CL, Cappai R, et al. (2010) Residues surrounding the glycosylphosphatidylinositol anchor attachment site of PrP modulate prion infection: insight from the resistance of rabbits to prion disease. J Virol 84: 6678-6686.
27. Swaminathan R, Ravi VK, Kumar S, Kumar MVS, Chandra N, (2011) Lysozyme: A model protein for amyloid research. Adv Protein Chem Struct Biol 84: 63-111.
28. Barghorn S, Biernat J, Mandelkow E, (2005) Purification of recombinant Tau protein and preparation of Alzheimer-paired helical filaments in vitro. Methods Mol Biol 299: 35-51.
29. Bocharova OV, Breydo L, Parfenov AS, Salnikov VV, Baskakov IV, (2005) In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrPSc. J Mol Biol 346: 645-659.
30. Chattopadhyay M, Durazo A, Sohn SH, Strong CD, Gralla EB, et al. (2008) Initiation and elongation in fibrillation of ALS-linked superoxide dismutase. Proc Natl Acad Sci USA 105: 18663-18668.
31. Lyons TJ, Nersissian A, Goto JJ, Zhu H, Gralla EB, et al. (1998) Metal ion reconstitution studies of yeast copper-zinc superoxide dismutase: the "phantom" subunit and the possible role of Lys7p. J Biol Inorg Chem 3: 650-662.
32. Arnaudov LN, de Vries R, (2005) Thermally induced fibrillar aggregation of hen egg white lysozyme. Biophys J 88: 515-526.
33. von Bergen M, Barghorn S, Müller SA, Pickhardt M, Biernat J, et al. (2006) The core of Tau-paired helical filaments studied by scanning transmission electron microscopy and limited proteolysis. Biochemistry 45: 6446-6457.
34. Makarava N, Lee CI, Ostapchenko VG, Baskakov IV, (2007) Highly promiscuous nature of prion polymerization. J Biol Chem 282: 36704-36713.
35. Krebs MRH, Wilkins DK, Chung EW, Pitkeathly MC, Chamberlain AK, et al. (2000) Formation and seeding of amyloid fibrils from wild-type hen lysozyme and a peptide fragment from the β-domain. J Mol Biol 300: 541-549.
36. van der Kamp MW, Daggett V, (2009) The consequences of pathogenic mutations to the human prion protein. Protein Eng Des Sel 22: 461-468.
37. Stathopulos PB, Rumfeldt JA, Scholz GA, Irani RA, Frey HE, et al. (2003) Cu/Zn superoxide dismutase mutants associated with amyotrophic lateral sclerosis show enhanced formation of aggregates in vitro. Proc Natl Acad Sci USA 100: 7021-7026.
38. Christiansen A, Wang Q, Samiotakis A, Cheung MS, Wittung-Stafshede P, (2010) Factors defining effects of macromolecular crowding on protein stability: an in vitro/in silico case study using cytochrome c. Biochemistry 49: 6519-6530.
39. Meiering EM, (2008) The threat of instability: neurodegeneration predicted by protein destabilization and aggregation propensity. PLoS Biol 6: e193.
40. Mandelkow E, Song YH, Schweers O, Marx A, Mandelkow EM, (1995) On the structure of microtubules, tau, and paired helical filaments. Neurobiol Aging 16: 347-354.
41. Aguzzi A, Sigurdson C, Heikenwaelder M, (2008) Molecular mechanisms of prion pathogenesis. Annu Rev Pathol 3: 11-40.
42. Peoc'h K, Manivet P, Beaudry P, Attane F, Besson G, et al. (2000) Identification of three novel mutations (E196K, V203I, E211Q) in the prion protein gene (PRNP) in inherited prion diseases with Creutzfeldt-Jakob disease phenotype. Hum Mutat 15: 482.
43. Swietnicki W, Petersen RB, Gambetti P, Surewicz WK, (1998) Familial mutations and the thermodynamic stability of the recombinant human prion protein. J Biol Chem 273: 31048-31052.
44. Vassall KA, Stubbs HR, Primmer HA, Tong MS, Sullivan SM, et al. (2011) Decreased stability and increased formation of soluble aggregates by immature superoxide dismutase do not account for disease severity in ALS. Proc Natl Acad Sci USA 108: 2210-2215.
45. Sun Y, Makarava N, Lee CI, Laksanalamai P, Robb FT, et al. (2008) Conformational stability of PrP amyloid fibrils controls their smallest possible fragment size. J Mol Biol 376: 1155-1167.
46. Conway KA, Lee SJ, Rochet JC, Ding TT, Williamson RE, et al. (2000) Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapy. Proc Natl Acad Sci USA 97: 571-576.
47. Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, et al. (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300: 486-489.
48. Silveira JR, Raymond GJ, Hughson AG, Race RE, Sim VL, et al. (2005) The most infectious prion protein particles. Nature 437: 257-261.